Prognostic effect of specific RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC).

George, B; Taylor, BW; Lasowski, M; Ritch, PS; Shreenivas, AV; Chakrabarti, S; Kamgar, M; Zimmermann, MT; Reddi, HV; Urrutia, R; Thomas, JP

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索